Lexaria Bioscience Corp. (NASDAQ:LEXXW) Short Interest Up 20.0% in March

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 2,400 shares, an increase of 20.0% from the February 28th total of 2,000 shares. Based on an average trading volume of 10,800 shares, the days-to-cover ratio is currently 0.2 days.

Lexaria Bioscience Trading Down 30.0 %

LEXXW traded down $0.09 during trading hours on Wednesday, hitting $0.21. The company’s stock had a trading volume of 300 shares, compared to its average volume of 12,279. Lexaria Bioscience has a 12 month low of $0.16 and a 12 month high of $2.00. The business’s 50-day moving average price is $0.32 and its 200-day moving average price is $0.62.

Lexaria Bioscience Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.